PR99483

SAN CARLOS, Calif., Jan.18, 2023 /PRNewswire=KYODO JBN/--

PANDORUM International Inc. has engaged EVOLUTION Life Science Partners to

assist the company in raising capital to fund the ongoing development of its

assets, primarily Bioengineered Liquid Cornea, advanced therapeutics to promote

cornea regeneration. The capital would support the clinical translation of the

first in class, first in human tissue regenerative reprogramming treatment via

Phase 1/2a studies, along with advancing Pandorum's proprietary technology

platform that enables production of advanced regenerative therapeutics with

control, scalability and consistency, for cornea and beyond. While PANDORUM is

currently engaged with USFDA for the clinical translation of its Cornea

pipeline, the broader objective is to move from therapeutics for single tissue

regeneration (such as, Cornea, Liver and Lung) to multi-tissue regenerative

therapy, with the potential to extending healthy lifespan. The company is also

exploring licensing and M&A opportunities of its assets with various

pharmaceutical organizations, with the assistance from EVOLUTION.

PANDORUM's cofounder and CEO, Tuhin Bhowmick stated, "We are excited with this

new partnership with EVOLUTION. Pandorum has reached an inflection point in its

journey which will require a larger fund raise and capital market expertise. We

believe that the partnership with EVOLUTION would help us achieve our immediate

objective as well as the broader vision to make Regenerative Medicine a

scalable, efficacious mainstream reality to treat millions in need across the

world."

Neal Fischer, Managing Director at EVOLUTION stated, "The partners at EVOLUTION

are excited about Pandorum's unique engineered exosome platform technology and

we look forward to assisting the company in getting access to capital and

exploring other strategic options to advance their pipeline."

EVOLUTION Life Science Partners is a life science investment bank that

specializes in licensing, strategic advisory, M&A, and capital raising. To

learn more about EVOLUTION, visit www.evolutionlsp.com

PANDORUM International Inc. is a regenerative medicine company with proprietary

tissue regeneration platform. Founded in 2011 by academic entrepreneurs,

PANDORUM has labs in San Carlos, USA and Bangalore, India. To learn more about

PANDORUM, visit www.pandorum.com

Source - PANDORUM International Inc